| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.004 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.004 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |